Top

Lung

Published in:

01-08-2016

Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans

Authors: Jonas Eckrich, Eva Herrmann, Sandra Voss, Ralf Schubert, Stefan Zielen, Martin Rosewich

Published in: Lung | Issue 4/2016

Abstract

Purpose

Bronchiolitis obliterans (BO) is an inadequately researched disease in terms of lung function as well as inflammatory profile. The short-term variation of these parameters has not been investigated. Therefore, the objective of this study was the investigation of lung function, sputum cells and cytokine profiles in BO at two visits within of four to six weeks.

Methods

Twenty patients with BO (median age = 14.6, range 8.3–24.3) performed lung function tests, airway reversibility testing and induction of sputum within four to six weeks. The cell composition in the sputum was analysed and cytokine levels of IL-1ß, IL-6 and IL-8 were determined by cytometric bead array analysis. The short-term variation was then statistically quantified and compared to that of twenty-two healthy controls. Furthermore, we compared data on short-term variation of lung function and airway inflammation with a previous investigation in these patients 10–15 months earlier.

Results

Patients with BO showed minimal variation of lung function (VCmax, FVC, FEV1, FEV1/VC, MEF25 and RV/TLC) and the inflammatory cell profile. The lung function data were significantly lower for FVC, FEV1, the Tiffeneau index and MEF25 compared to the control group, whereas RV/TLC was significantly increased. Analysis of the BO sputum cells showed a consistent neutrophil inflammation. The levels of inflammatory cytokines IL-1ß, IL-6 and IL-8 had a great variability.

Conclusions

The short-term variability of sputum neutrophilia and lung function is low in BO patients. This finding should be considered to identify successful treatment in the individual patient and could be used as endpoints for future BO-related studies.

Available only for authorised users

Verleden SE, Vasilescu DM, Willems S, Ruttens D, Vos R, Vandermeulen E, Hostens J, McDonough JE, Verbeken EK, Verschakelen J, Van Raemdonck DE, Rondelet B, Knoop C, Decramer M, Cooper J, Hogg JC, Verleden GM, Vanaudenaerde BM (2014) The site and nature of airway obstruction after lung transplantation. Am J Respir Crit care Med 189(3):292–300. doi:10.1164/rccm.201310-1894OC CrossRefPubMed

Hardy KA, Schidlow DV, Zaeri N (1988) Obliterative bronchiolitis in children. Chest 93(3):460–466CrossRefPubMed

Aguerre V, Castanos C, Pena HG, Grenoville M, Murtagh P (2010) Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatric Pulm 45(12):1180–1185. doi:10.1002/ppul.21304 CrossRef

Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T, Robin M, Ribaud P, Socie G, Tazi A (2013) Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplant 48(6):819–824. doi:10.1038/bmt.2012.241 CrossRefPubMed

Solomon M, Grasemann H, Keshavjee S (2010) Pediatric lung transplantation. Pediatric Clin N Am 57(2):375–391. doi:10.1016/j.pcl.2010.01.017 CrossRef

Castro-Rodriguez JA, Daszenies C, Garcia M, Meyer R, Gonzales R (2006) Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatric Pulmonol 41(10):947–953. doi:10.1002/ppul.20472 CrossRef

Colom AJ, Teper AM, Vollmer WM, Diette GB (2006) Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 61(6):503–506. doi:10.1136/thx.2005.044909 CrossRefPubMedPubMedCentral

Kim CK, Kim SW, Kim JS, Koh YY, Cohen AH, Deterding RR, White CW (2001) Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest 120(4):1101–1106CrossRefPubMed

Alvarez AE, Marson FA, Bertuzzo CS, Arns CW, Ribeiro JD (2013) Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. J Pediatr 89(6):531–543. doi:10.1016/j.jped.2013.02.022 CrossRef

10.

Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR, Committee IAEBTF, Committee IAEBTF (2014) An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur respir J 44(6):1479–1503. doi:10.1183/09031936.00107514 CrossRefPubMed

11.

Rosewich M, Zissler UM, Kheiri T, Voss S, Eickmeier O, Schulze J, Herrmann E, Ducker RP, Schubert R, Zielen S (2015) Airway inflammation in children and adolescents with bronchiolitis obliterans. Cytokine 73(1):156–162. doi:10.1016/j.cyto.2014.10.026 CrossRefPubMed

12.

Colom AJ, Maffey A, Garcia Bournissen F, Teper A (2015) Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up. Thorax 70(2):169–174. doi:10.1136/thoraxjnl-2014-205328 CrossRefPubMed

13.

Rosewich M, Eckrich J, Zielen S (2015) Long-term lung function in postinfectious bronchiolitis obliterans. Thorax 70(8):792. doi:10.1136/thoraxjnl-2015-206998 CrossRefPubMed

14.

Teixeira MF, Rodrigues JC, Leone C, Adde FV (2013) Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children. Chest 144(3):974–980. doi:10.1378/chest.12-2280 CrossRefPubMed

15.

Tomikawa SO, Adde FV, da Silva Filho LV, Leone C, Rodrigues JC (2014) Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy. Orphanet J Rare Dis 9:128. doi:10.1186/s13023-014-0128-2 CrossRefPubMedPubMedCentral

16.

Suresh Babu K, Kastelik J, Morjaria JB (2013) Role of long term antibiotics in chronic respiratory diseases. Respir Med 107(6):800–815. doi:10.1016/j.rmed.2013.02.009 CrossRefPubMed

17.

Schulze J, Voss S, Zissler U, Rose MA, Zielen S, Schubert R (2012) Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge. Respir Res 13:78. doi:10.1186/1465-9921-13-78 CrossRefPubMedPubMedCentral

18.

Eickmeier O, Huebner M, Herrmann E, Zissler U, Rosewich M, Baer PC, Buhl R, Schmitt-Grohe S, Zielen S, Schubert R (2010) Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine 50(2):152–157. doi:10.1016/j.cyto.2010.02.004 CrossRefPubMed

19.

Soubani AO, Uberti JP (2007) Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 29(5):1007–1019. doi:10.1183/09031936.00052806 CrossRefPubMed

20.

Todd JL, Palmer SM (2011) Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest 140(2):502–508. doi:10.1378/chest.10-2838 CrossRefPubMed

21.

Gibson PG, Simpson JL (2009) The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 64(8):728–735. doi:10.1136/thx.2008.108027 CrossRefPubMed

22.

Barisione G, Bacigalupo A, Crimi E, Brusasco V (2011) Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation. Chest 139(3):633–639. doi:10.1378/chest.10-1442 CrossRefPubMed

23.

De Baets F (2011) Bronchiolitis obliterans in children: a ghostly journey to the origin. Allergol Immunopathol 39(5):251–252. doi:10.1016/j.aller.2011.05.003 CrossRef

24.

Madill J, Aghdassi E, Arendt BM, Gutierrez C, Singer L, Chow CW, Keshavjee S, Allard JP (2009) Oxidative stress and nutritional intakes in lung patients with bronchiolitis obliterans syndrome. Transplant Proc 41(9):3838–3844. doi:10.1016/j.transproceed.2009.04.012 CrossRefPubMed

25.

Regamey N, Jeffery PK, Alton EW, Bush A, Davies JC (2011) Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax 66(7):624–629. doi:10.1136/thx.2009.134106 CrossRefPubMed

26.

Cazzato S, Poletti V, Bernardi F, Loroni L, Bertelli L, Colonna S, Zappulla F, Timoncini G, Cicognani A (2008) Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatric Pulm 43(4):381–390. doi:10.1002/ppul.20784 CrossRef

27.

DeNicola MM, Weigt SS, Belperio JA, Reed EF, Ross DJ, Wallace WD (2013) Pathologic findings in lung allografts with anti-HLA antibodies. J Heart Lung Transplant 32(3):326–332. doi:10.1016/j.healun.2012.11.018 CrossRefPubMed

28.

Moermans C, Poulet C, Henket M, Bonnet C, Willems E, Baron F, Beguin Y, Louis R (2013) Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respir Med 107(12):2071–2080. doi:10.1016/j.rmed.2013.10.013 CrossRefPubMed

29.

Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C (2015) A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax. doi:10.1136/thoraxjnl-2014-205998

30.

Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM (2008) A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 32(4):832–843. doi:10.1183/09031936.00134307 CrossRefPubMed

31.

Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE (2006) Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 174(5):566–570. doi:10.1164/rccm.200601-071OC CrossRefPubMed

32.

Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, Schoonis A, Nawrot TS, Dupont LJ, Verleden GM (2011) A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 37(1):164–172. doi:10.1183/09031936.00068310 CrossRefPubMed

33.

Leaker BR, Barnes PJ, O’Connor B (2013) Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist. Respir Res 14:137. doi:10.1186/1465-9921-14-137 CrossRefPubMedPubMedCentral

34.

Hechinger AK, Smith BA, Flynn R, Hanke K, McDonald-Hyman C, Taylor PA, Pfeifer D, Hackanson B, Leonhardt F, Prinz G, Dierbach H, Schmitt-Graeff A, Kovarik J, Blazar BR, Zeiser R (2015) Therapeutic activity of multiple common gamma-chain cytokine inhibition in acute and chronic GVHD. Blood 125(3):570–580. doi:10.1182/blood-2014-06-581793 CrossRefPubMedPubMedCentral

35.

Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, Croze RH, Carlo T, Pfeffer MA, Levy BD (2013) Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol 6(2):256–266. doi:10.1038/mi.2012.66 CrossRefPubMed

36.

Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schone H, Kirsten AM, Magnussen H, Rabe KF, Goldmann T, Watz H (2015) Multi-analyte profiling of inflammatory mediators in COPD sputum–the effects of processing. Cytokine 71(2):401–404. doi:10.1016/j.cyto.2014.10.008 CrossRefPubMed

Title: Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans
Authors: Jonas Eckrich
Eva Herrmann
Sandra Voss
Ralf Schubert
Stefan Zielen
Martin Rosewich
Publication date: 01-08-2016
Publisher: Springer US
Published in: Lung / Issue 4/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-016-9907-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2016

Change in Diaphragmatic Thickness During the Respiratory Cycle Predicts Extubation Success at Various Levels of Pressure Support Ventilation

A scoring system for predicting the survival prognosis of patients receiving stereotactic body radiation therapy (SBRT) for 1–3 lung metastases

Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections

Effect of Maternal Electroacupuncture on Perinatal Nicotine Exposure-Induced Lung Phenotype in Offspring

Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page